February 10, 2018 / 12:13 AM / in 15 days

Appeals court ends Merck patent challenge to Amneal's generic Nasonex

A federal appeals court on Friday upheld a patent ruling that allowed generic drug maker Amneal Pharmaceuticals LLC to launch a low-cost version of Merck & Co Inc’s nasal spray Nasonex.

The U.S. Federal Circuit Court of Appeals affirmed a lower court ruling that Amneal’s generic version of Nasonex did not infringe a Merck patent covering the spray’s active ingredient.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2snYiA5

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below